In this course you will learn about the best practices in collaborating with and referring to NP/MDs for specialized assessments for your patients. We will include information on expectations around documentation and collaborative communication. We will also review some of the testing that is available for patients with complex chronic disease, cancer and for patients wanting to explore aging and longevity. Course is pending approval for 1 category A CME with CONO.
In the ever evolving landscape of complex chronic disease and longevity, the role of prescription medication both in an on label and off label setting is growing in terms of its utility in patients. In this course we will discuss how to collaborate effectively with integrative minded medical doctors and nurse practitioners with patients receiving prescriptive medications in an integrative setting. Topics will include: what are the important factors related to off-label prescribing, how best to complete a detailed referral, how to communicate with providers around the status of patients and their prescription medications, and a variety of other topics to ensure you are both meeting the needs of the patient as well as any regulatory requirements. This is a prerequisite course before completing referrals through Onan for patients needing prescription medication.
Delegation is an important part of collaborative practice. In this lesson, you will learn about the regulatory requirements for both accepting and giving delegation from an Ontario naturopathic perspective. We will look at both the College of Naturopaths of Ontario's guidelines for delegation as well as the Federation of Health Regulatory Colleges of Ontario's guidelines. You will be provided with a variety of resources as well as process recommendations to ensure that you are meeting both the regulatory requirements as well as, more importantly, the needs of your patients. This is an important prerequisite course before accepting delegation through ONIN
Curcumin is a very important therapeutic agent in integrative medicine. We all know curcumin has an incredible array of preclinical and some early clinical research exploring its utility in a variety of diseases, but it is efficacy is often limited by its poor absorption. Intravenous administration is one way to help avoid this and get much higher concentrations to deliver better therapeutic efficacy. In this lesson, we will review the evidence behind curcumin's use from an intravenous perspective. We will discuss what types of clinical trials have been done that provide evidence both for the safe administration and management of patients receiving IV curcumin. We will talk about protocols for administration, safe dosing, and patient assessment and monitoring. This is an important prerequisite for referring patients to receive delegation for infusion of curcumin with ONIN.
DCA has the potential to be a useful metabolic therapy in cancer care with several encouraging clinical trials. It was first used as a therapy for inborn errors of metabolism and is now an orphan drug throughout most of the world. Due to its effects on mitochondrial activity, it can create important alterations in cancer cell metabolism which can lead to apoptosis. In this lesson, we will look at the various ways in which DCA can be used as an integrative cancer therapeutic. We will also explore its safe administration with patients, including assessment and monitoring.
Artesunate is a semisynthetic derivative of artemisinin from the artemisia annua plant (chinese wormwood) and has been an important therapeutic around the world for malaria. Its use in traditional Chinese medicine dates back thousands of years. Recent research has shown it may play a role in the supportive care in patients with cancer and chronic infections. In this course you will learn the evidence behind its use and how it can be safely applied in patients.
Nicotinamide Adenine Dinucleotide, or NAD, is an emerging therapeutic that is implicated in a variety of metabolic processes and is emerging as an important therapeutic for fatigue, addiction, cognitive disorders and general wellness and longevity. In this lesson, we will review the clinical research that is currently available for intravenous NAD therapy. In addition, we will discuss the assessment and monitoring of patients receiving NAD therapy and its safe administration, including protocols for use in various situations like addiction, chronic fatigue, neurological disease and more.
Phosphatidylcholine is a very important therapeutic in integrative medicine. In this lesson you will learn about the role of intravenous phosphatidylcholine in integrative care from an in an intravenous infusion based context. We will review some of the fundamental processes involved in cardiovascular disease and endothelial dysfunction and how phosphatidylcholine may positively impact these processes. We will review the clinical research on the use of intravenous phosphatidylcholine, particularly in cardiovascular disease, but also on potential neurodegenerative and inflammatory processes. Finally, we will discuss the best practices for administration, how to both assess patients for appropriateness of treatment, administer phosphatidylcholine safely and effectively, and monitor patients. This is an important prerequisite for referring patients to potentially receive delegation for infusion based phosphatidylcholine in your practice
Central venous catheters are important vascular access technologies that can ensure safe vascular access for our patients. In this course you will learn the various central venous catheters that you will encounter in clinical practice and how to access them safely. You will also learn the guidelines for heparin locking of catheters in patients with central line. Once you have completed the online lessons you will have to book an in-person practical session at the Marsden Centre to complete your certification.
Intravenous Glycyrrhizic acid (GZA) is a well researched long used therapeutic for viral and hepatic complaints. In this course you will learn the mechanism of actions of GZA and how to apply it safely and effectively in your patients.
EDTA has long been used as an integrative therapy for cardiovascular disease and toxic metal detoxification. It is an important chelator, particularly for the metals of lead, cadmium, arsenic and even mercury. Recently with large clinical trial including the TACT ONE trial, its efficacy in cardiovascular disease for the prevention of secondary cardiovascular events post myocardial infarction infarction has been validated. In this lesson, we will review the role of toxic metal in cardiovascular disease. We will also discuss the clinical evidence for the use of EDTA in cardiovascular disease and in toxic metal detoxification. Finally, we will discuss the safe use, including patient selection, assessment and monitoring, as well as various protocols including dosing and frequency of administration.
Stealth pathogens are microorganisms characterized by their ability to remain undetected by the immune system through various mechanisms, such as intracellular habitation, antigenic variation, and immune suppression. this can lead to chronic infection/reinfection. Examples of organisms that are stealth pathogens include certain bacteria (e.g., Chlamydia pneumoniae), viruses (e.g., Epstein-Barr Virus), and fungi. In this webinar we will explore the connection between stealth pathogens and chronic diseases, emphasizing conditions like chronic fatigue syndrome, Lyme disease, and certain autoimmune disorders. The webinar will detail how stealth pathogens contribute to disease persistence and exacerbation through chronic inflammation, immune dysregulation, and molecular mimicry. The need for advanced diagnostic methods, including molecular techniques (PCR) to identify these pathogens will be introduced along. Finally, we will review advanced holistic treatment strategies aimed at eliminating the pathogen and mitigating the effects on immune function and inflammation. Application has been made for 1 hour of CONO category A credit.
Learn about the role of peptides in the treatment of and prevention of disease and its contribution to healthy aging and longevity. Focus of this discussion will be on what peptides are available in Canada currently and how they can be administered for best effect.
Low Dose Naltrexone (LDN) has been used as an immunomodulating therapy in inflammatory disease for decades. In this webinar we will discuss the history of LDN use and its known mechanisms of action on the immune system and cancer cells. We will review the preclinical and clinical research supporting its use in chronic diseases like autoimmune conditions, neuroinflammatory conditions and cancer. We will discuss prescribing guidelines including dose titration, maintenance dosing, managing side effects and contraindications/interactions so NDs can assist in comanaging patients on this treatment. Case examples will be presented. Application has been made for 1 hour of CONO category A pharmacology credit.